Global Biosimilars/Follow-on-Biologics Sales Market Report 2024
The global Biosimilars/Follow-on-Biologics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilars/Follow-on-Biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Peptide
Others
Segment by Application
Blood Disorders
Oncology Diseases
Chronic and Autoimmune Diseases
Growth Hormone Deficiencies
Others
The Biosimilars/Follow-on-Biologics market is analysed and market size information is provided by regions (countries).
Segment by Application
, the Biosimilars/Follow-on-Biologics market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Novartis
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion
Biocon
Hospira
Merck Group
Biogen idec, Inc.
Genentech (Roche Group)

Table of Content
1 Biosimilars/Follow-on-Biologics Market Overview
1.1 Biosimilars/Follow-on-Biologics Product Scope
1.2 Biosimilars/Follow-on-Biologics Segment by Type
1.2.1 Global Biosimilars/Follow-on-Biologics Sales by Type (2016 & 2021 & 2027)
1.2.2 Human Growth Hormone
1.2.3 Erythropoietin
1.2.4 Monoclonal Antibodies
1.2.5 Insulin
1.2.6 Interferon
1.2.7 Granulocyte-Colony Stimulating Factor
1.2.8 Peptide
1.2.9 Others
1.3 Biosimilars/Follow-on-Biologics Segment by Application
1.3.1 Global Biosimilars/Follow-on-Biologics Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Blood Disorders
1.3.3 Oncology Diseases
1.3.4 Chronic and Autoimmune Diseases
1.3.5 Growth Hormone Deficiencies
1.3.6 Others
1.4 Biosimilars/Follow-on-Biologics Market Estimates and Forecasts (2016-2027)
1.4.1 Global Biosimilars/Follow-on-Biologics Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Biosimilars/Follow-on-Biologics Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Biosimilars/Follow-on-Biologics Price Trends (2016-2027)
2 Biosimilars/Follow-on-Biologics Estimates and Forecasts by Region
2.1 Global Biosimilars/Follow-on-Biologics Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Biosimilars/Follow-on-Biologics Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Biosimilars/Follow-on-Biologics Sales Market Share by Region (2016-2021)
2.2.2 Global Biosimilars/Follow-on-Biologics Revenue Market Share by Region (2016-2021)
2.3 Global Biosimilars/Follow-on-Biologics Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Biosimilars/Follow-on-Biologics Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Biosimilars/Follow-on-Biologics Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Biosimilars/Follow-on-Biologics Estimates and Projections (2016-2027)
2.4.2 Europe Biosimilars/Follow-on-Biologics Estimates and Projections (2016-2027)
2.4.3 China Biosimilars/Follow-on-Biologics Estimates and Projections (2016-2027)
2.4.4 Japan Biosimilars/Follow-on-Biologics Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Biosimilars/Follow-on-Biologics Estimates and Projections (2016-2027)
2.4.6 India Biosimilars/Follow-on-Biologics Estimates and Projections (2016-2027)
3 Global Biosimilars/Follow-on-Biologics Competition Landscape by Players
3.1 Global Top Biosimilars/Follow-on-Biologics Players by Sales (2016-2021)
3.2 Global Top Biosimilars/Follow-on-Biologics Players by Revenue (2016-2021)
3.3 Global Biosimilars/Follow-on-Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biosimilars/Follow-on-Biologics as of 2020)
3.4 Global Biosimilars/Follow-on-Biologics Average Price by Company (2016-2021)
3.5 Manufacturers Biosimilars/Follow-on-Biologics Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Biosimilars/Follow-on-Biologics Market Size by Type
4.1 Global Biosimilars/Follow-on-Biologics Historic Market Review by Type (2016-2021)
4.1.1 Global Biosimilars/Follow-on-Biologics Sales Market Share by Type (2016-2021)
4.1.2 Global Biosimilars/Follow-on-Biologics Revenue Market Share by Type (2016-2021)
4.1.3 Global Biosimilars/Follow-on-Biologics Price by Type (2016-2021)
4.2 Global Biosimilars/Follow-on-Biologics Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Biosimilars/Follow-on-Biologics Sales Forecast by Type (2022-2027)
4.2.2 Global Biosimilars/Follow-on-Biologics Revenue Forecast by Type (2022-2027)
4.2.3 Global Biosimilars/Follow-on-Biologics Price Forecast by Type (2022-2027)
5 Global Biosimilars/Follow-on-Biologics Market Size by Application
5.1 Global Biosimilars/Follow-on-Biologics Historic Market Review by Application (2016-2021)
5.1.1 Global Biosimilars/Follow-on-Biologics Sales Market Share by Application (2016-2021)
5.1.2 Global Biosimilars/Follow-on-Biologics Revenue Market Share by Application (2016-2021)
5.1.3 Global Biosimilars/Follow-on-Biologics Price by Application (2016-2021)
5.2 Global Biosimilars/Follow-on-Biologics Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Biosimilars/Follow-on-Biologics Sales Forecast by Application (2022-2027)
5.2.2 Global Biosimilars/Follow-on-Biologics Revenue Forecast by Application (2022-2027)
5.2.3 Global Biosimilars/Follow-on-Biologics Price Forecast by Application (2022-2027)
6 North America Biosimilars/Follow-on-Biologics Market Facts & Figures
6.1 North America Biosimilars/Follow-on-Biologics Sales by Company
6.1.1 North America Biosimilars/Follow-on-Biologics Sales by Company (2016-2021)
6.1.2 North America Biosimilars/Follow-on-Biologics Revenue by Company (2016-2021)
6.2 North America Biosimilars/Follow-on-Biologics Sales Breakdown by Type
6.2.1 North America Biosimilars/Follow-on-Biologics Sales Breakdown by Type (2016-2021)
6.2.2 North America Biosimilars/Follow-on-Biologics Sales Breakdown by Type (2022-2027)
6.3 North America Biosimilars/Follow-on-Biologics Sales Breakdown by Application
6.3.1 North America Biosimilars/Follow-on-Biologics Sales Breakdown by Application (2016-2021)
6.3.2 North America Biosimilars/Follow-on-Biologics Sales Breakdown by Application (2022-2027)
7 Europe Biosimilars/Follow-on-Biologics Market Facts & Figures
7.1 Europe Biosimilars/Follow-on-Biologics Sales by Company
7.1.1 Europe Biosimilars/Follow-on-Biologics Sales by Company (2016-2021)
7.1.2 Europe Biosimilars/Follow-on-Biologics Revenue by Company (2016-2021)
7.2 Europe Biosimilars/Follow-on-Biologics Sales Breakdown by Type
7.2.1 Europe Biosimilars/Follow-on-Biologics Sales Breakdown by Type (2016-2021)
7.2.2 Europe Biosimilars/Follow-on-Biologics Sales Breakdown by Type (2022-2027)
7.3 Europe Biosimilars/Follow-on-Biologics Sales Breakdown by Application
7.3.1 Europe 129 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 129 Sales Breakdown by Application (2022-2027)
8 China Biosimilars/Follow-on-Biologics Market Facts & Figures
8.1 China Biosimilars/Follow-on-Biologics Sales by Company
8.1.1 China Biosimilars/Follow-on-Biologics Sales by Company (2016-2021)
8.1.2 China Biosimilars/Follow-on-Biologics Revenue by Company (2016-2021)
8.2 China Biosimilars/Follow-on-Biologics Sales Breakdown by Type
8.2.1 China Biosimilars/Follow-on-Biologics Sales Breakdown by Type (2016-2021)
8.2.2 China Biosimilars/Follow-on-Biologics Sales Breakdown by Type (2022-2027)
8.3 China Biosimilars/Follow-on-Biologics Sales Breakdown by Application
8.3.1 China 154 Sales Breakdown by Application (2016-2021)
8.3.2 China 154 Sales Breakdown by Application (2022-2027)
9 Japan Biosimilars/Follow-on-Biologics Market Facts & Figures
9.1 Japan Biosimilars/Follow-on-Biologics Sales by Company
9.1.1 Japan Biosimilars/Follow-on-Biologics Sales by Company (2016-2021)
9.1.2 Japan Biosimilars/Follow-on-Biologics Revenue by Company (2016-2021)
9.2 Japan Biosimilars/Follow-on-Biologics Sales Breakdown by Type
9.2.1 Japan Biosimilars/Follow-on-Biologics Sales Breakdown by Type (2016-2021)
9.2.2 Japan Biosimilars/Follow-on-Biologics Sales Breakdown by Type (2022-2027)
9.3 Japan Biosimilars/Follow-on-Biologics Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Biosimilars/Follow-on-Biologics Market Facts & Figures
10.1 Southeast Asia Biosimilars/Follow-on-Biologics Sales by Company
10.1.1 Southeast Asia Biosimilars/Follow-on-Biologics Sales by Company (2016-2021)
10.1.2 Southeast Asia Biosimilars/Follow-on-Biologics Revenue by Company (2016-2021)
10.2 Southeast Asia Biosimilars/Follow-on-Biologics Sales Breakdown by Type
10.2.1 Southeast Asia Biosimilars/Follow-on-Biologics Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Biosimilars/Follow-on-Biologics Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Biosimilars/Follow-on-Biologics Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)
11 India Biosimilars/Follow-on-Biologics Market Facts & Figures
11.1 India Biosimilars/Follow-on-Biologics Sales by Company
11.1.1 India Biosimilars/Follow-on-Biologics Sales by Company (2016-2021)
11.1.2 India Biosimilars/Follow-on-Biologics Revenue by Company (2016-2021)
11.2 India Biosimilars/Follow-on-Biologics Sales Breakdown by Type
11.2.1 India Biosimilars/Follow-on-Biologics Sales Breakdown by Type (2016-2021)
11.2.2 India Biosimilars/Follow-on-Biologics Sales Breakdown by Type (2022-2027)
11.3 India Biosimilars/Follow-on-Biologics Sales Breakdown by Application
11.3.1 India Biosimilars/Follow-on-Biologics Sales Breakdown by Application (2016-2021)
11.3.2 India Biosimilars/Follow-on-Biologics Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Biosimilars/Follow-on-Biologics Business
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Business Overview
12.1.3 Novartis Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis Biosimilars/Follow-on-Biologics Products Offered
12.1.5 Novartis Recent Development
12.2 Synthon Pharmaceuticals
12.2.1 Synthon Pharmaceuticals Corporation Information
12.2.2 Synthon Pharmaceuticals Business Overview
12.2.3 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Products Offered
12.2.5 Synthon Pharmaceuticals Recent Development
12.3 Teva Pharmaceutical Industries
12.3.1 Teva Pharmaceutical Industries Corporation Information
12.3.2 Teva Pharmaceutical Industries Business Overview
12.3.3 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Products Offered
12.3.5 Teva Pharmaceutical Industries Recent Development
12.4 LG Life Sciences
12.4.1 LG Life Sciences Corporation Information
12.4.2 LG Life Sciences Business Overview
12.4.3 LG Life Sciences Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2016-2021)
12.4.4 LG Life Sciences Biosimilars/Follow-on-Biologics Products Offered
12.4.5 LG Life Sciences Recent Development
12.5 Celltrion
12.5.1 Celltrion Corporation Information
12.5.2 Celltrion Business Overview
12.5.3 Celltrion Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Celltrion Biosimilars/Follow-on-Biologics Products Offered
12.5.5 Celltrion Recent Development
12.6 Biocon
12.6.1 Biocon Corporation Information
12.6.2 Biocon Business Overview
12.6.3 Biocon Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Biocon Biosimilars/Follow-on-Biologics Products Offered
12.6.5 Biocon Recent Development
12.7 Hospira
12.7.1 Hospira Corporation Information
12.7.2 Hospira Business Overview
12.7.3 Hospira Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Hospira Biosimilars/Follow-on-Biologics Products Offered
12.7.5 Hospira Recent Development
12.8 Merck Group
12.8.1 Merck Group Corporation Information
12.8.2 Merck Group Business Overview
12.8.3 Merck Group Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Merck Group Biosimilars/Follow-on-Biologics Products Offered
12.8.5 Merck Group Recent Development
12.9 Biogen idec, Inc.
12.9.1 Biogen idec, Inc. Corporation Information
12.9.2 Biogen idec, Inc. Business Overview
12.9.3 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Products Offered
12.9.5 Biogen idec, Inc. Recent Development
12.10 Genentech (Roche Group)
12.10.1 Genentech (Roche Group) Corporation Information
12.10.2 Genentech (Roche Group) Business Overview
12.10.3 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Products Offered
12.10.5 Genentech (Roche Group) Recent Development
13 Biosimilars/Follow-on-Biologics Manufacturing Cost Analysis
13.1 Biosimilars/Follow-on-Biologics Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Biosimilars/Follow-on-Biologics
13.4 Biosimilars/Follow-on-Biologics Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Biosimilars/Follow-on-Biologics Distributors List
14.3 Biosimilars/Follow-on-Biologics Customers
15 Market Dynamics
15.1 Biosimilars/Follow-on-Biologics Market Trends
15.2 Biosimilars/Follow-on-Biologics Drivers
15.3 Biosimilars/Follow-on-Biologics Market Challenges
15.4 Biosimilars/Follow-on-Biologics Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer